| [Actions of keratinocyte growth factor in leukemic mice allogeneic umbilical cord blood cell transplantation]. | |
| | |
MedLine Citation:
|
PMID: 22333552 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
OBJECTIVE: To explore the actions of keratinocyte growth factor (KGF) in leukemic mice allogeneic umbilical cord blood cell transplantation (UCBT) and elucidate its mechanism. METHODS: Peripheral blood drawn from the litters of C57BL/6 females was used as umbilical cord blood (UCB) graft. BALB/c mice were randomly divided into 7 groups (n = 12 each). The grouping was as follows. Control group 1, inoculated with leukemia. Control group 2, inoculated with leukemia at -4 d and total body irradiation (TBI) treatment. Control group 3, TBI treatment and reconstituted with 2 × 10(6) UCB-TNCs. Control group 4, injected with PBS subcutaneously, TBI treatment and reconstituted with UCB-TNCs with platelet transfusion. Control group 5, inoculated with leukemia, injected with PBS subcutaneously, TBI treatment and reconstituted with UCB-TNCs with platelet transfusion. Experiment group 1, injected with KGF subcutaneously, TBI treatment and reconstituted with UCB-TNCs with platelet transfusion. Experiment group 2, inoculated with leukemia, injected with KGF subcutaneously, TBI treatment and reconstituted with UCB-TNCs with platelet transfusion. The survival status, pathohistological changes, splenic lymphoid cell subsets and thymic output post-UCBT were compared between groups. RESULTS: The survival time of control group 1 was (11.1 ± 1.5) days and all died of leukemia. The survival time of control group 2 was (11.5 ± 2.5) days and all died of aplasia. Five of 12 mice of control group 3 survived for 100 days and 7 mice died of visceral hemorrhage. Four of 12 mice of control group 5 survived for 100 days and 8 mice died of leukemia with a survival rate of 33.3%. Nine of 12 mice of experiment group 2 survived for 100 days and 3 mice died of leukemia with a survival rate of 75.0%. The survival was prolonged in experiment group 2 mice as compared with that of control group 5 mice (χ(2) = 4.996, P = 0.0254). The splenic T, NK and B cell counts in control group 4 mice at +35 d were (9.32 ± 0.48) × 10(6), (1.59 ± 0.11) × 10(6) and (18.74 ± 2.01) × 10(6) respectively. While in group 6 mice at +35 d were (13.20 ± 1.14) × 10(6), (1.75 ± 0.12) × 10(6) and (20.36 ± 0.86) × 10(6) respectively. The counts of T cell and NK cell of group 6 were higher than those of group 4 (both P < 0.05). The level of signal joint T-Cell receptor excision circles (sjTRECs) in control group 4 mice was (167 ± 17) copies per 10(5) cells while that of experiment group 1 mice (228 ± 24) copies per 10(5) cells. They were higher than that of control mice (P = 0.002). CONCLUSION: Hematopoietic stem/precursor cells are abundant in full-term murine fetal peripheral blood. The infusion of KGF reduces the post-UCBT relapse of leukemia through the enhancement of thymic output. |
| | |
Authors:
|
Guang-Hua Chen; Yi Wang; Shu-Min Qiao; Yu-Feng Feng; Zi-Ling Zhu; De-Pei Wu |
Publication Detail:
|
Type: English Abstract; Journal Article |
Journal Detail:
|
Title: Zhonghua yi xue za zhi Volume: 91 ISSN: 0376-2491 ISO Abbreviation: Zhonghua Yi Xue Za Zhi Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2012-02-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7511141 Medline TA: Zhonghua Yi Xue Za Zhi Country: China |
Other Details:
|
Languages: chi Pagination: 2863-7 Citation Subset: IM |
Affiliation:
|
Jiangsu Institute of Hematology, Key Laboratory of Thrombosis & Hemostasis, Ministry of Health, First Affiliated Hospital, Soochow University, Suzhou 215006, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [Diagnosis and treatment of cystic renal cell carcinoma: a report of 14 cases].
Next Document: [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].